Invited Discussant of the German-Austrian Study Group Report

E. A. Loeliger

doi:10.1055/s-0039-1687660

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1979; 41(01): 249-253
DOI: 10.1055/s-0039-1687660

Dedication

Schattauer GmbH

Invited Discussant of the German-Austrian Study Group Report

Authors

E. A. Loeliger

¹Interne Geneeskunde, Academisch Ziekenhuis, Leiden, The Netherlands

Abstract

PDF Download

PDF (582 kb)

References

Reference
1 Aspenström G., and Korsan-Bengtsen K.. 1964; A double-blind study of dicumarol prophylaxis in coronary heart disease.. Acta Medica Scandinavica 776: 563.
2 Barrillon A., Kusmierek J., Rochemaure J., and Gerbaux A.. 1975; Thromboses coronaires et traitement anticoagulant au long cours.. Archives des Maladies du Cœur et des Vaisseaux 68: 147.
3 Bjerkelund C.J.. 1957 The effect of long-term treatment with dicoumarol in myocardial infarction.. Acta Medica Scandinavica, suppl. 330.
4 Borchgrevink C.F.. 1963; Long-term anticoagulant therapy in angina pectoris and myocardial infarction.. Pharmakotherapia 1: 109.
5 Dijk-Wierda C.A. van, Halem-Visser L.P. van, Hoeff-Van Halem R. van der, and Loeliger E.A.. 1978; The preparation of control blood for external quality assessment programs in oral anticoagulant control.. Thrombosis and Haemostasis 39: 210.
6 Dijk-Wierda C.A. van, Hermans J., Loeliger E.A., and Roos J.. 1977; Interlaboratory oral anticoagulant quality assessment by the Netherlands Federation of Thrombosis Services.. Thrombosis and Haemostasis 37: 509.
7 Duckert F., and Marbet G.A.. 1977; Die Kontrolle der oralen Antikoagulation der therapeutische Bereich.. Schweizerische medizinische Wochenschrift 107: 1308.
8 Gifford R.H., and Feinstein A.R.. 1969; A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction.. New England Journal of Medicine 280: 351.
9 Gross M., Vaid A.K., Levine H.S., and Hasson J.. 1972; Anticoagulant therapy in myocardial infarction.. An overview of methodology. American Journal of Medicine 52: 421.
10 International Anticoagulant Review Group. 1970; Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction.. Lancet 1: 203.
11 Jorgensen L., Chandler A.B., and Borchgrevink C.F.. 1971; Acute lesions of coronary arteries in anticoagulant treated and in untreated patients.. Atherosclerosis 13: 21.
12 Loeliger E.A.. 1979 The therapeutic optimal range. A proposal.. Thrombosis and Haemostasis. To be published.
13 Loeliger E.A., and Halem-Visser L.P. van. 1978; Thromboplastin Calibration. Experience of the Dutch Reference Laboratory for Anticoagulant Control.. Thrombosis and Haemostasis 40: 272.
14 Loeliger E.A., Hensen A., Kroes F., Dijk L.M. van, Fekkes N., Jonge H. de, and Hemker H.C.. 1967; A double-blind trial on long-term anticoagulant treatment after myocardial infarction.. Acta Medica Scandinavica 182: 549.
15 Medical Research Council. 1964; An assessment of long-term anticoagulant administration after cardiac infarction.. Report of the working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. British Medical Journal 2: 837.
16 Meuwissen O.J.A.T., Vervoorn A.C., Cohen O., Jordan F.L.J, and Nelemans F.A.. 1969; Double-blind trial of long-term anticoagulant treatment after myocardial infarction.. Acta Medica Scandinavica 186: 361.
17 Molne K., and Hjort P.F.. 1965; Myocardial infarction during anticoagulant therapy.. Acta Medica Scandinavica 777: 571.
18 Sorensen O.H., Friis T., Whitta Jorgensen A., Borch Jorgensen H., and Nissen N.I.. 1969; Anticoagulant treatment of acute coronary thrombosis.. Acta Medica Scandinavica 185: 65.